Cargando…
The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights
There is an increased cardiovascular (CV) risk in axial spondyloarthritis (axSpA), leading to increased CV mortality and morbidity in these patients. The factors that may explain this enhanced CV risk in axSpA are multiple, including traditional CV risk factors such as smoking, but also the inflamma...
Autor principal: | Toussirot, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630576/ https://www.ncbi.nlm.nih.gov/pubmed/34859023 http://dx.doi.org/10.3389/fmed.2021.782150 |
Ejemplares similares
-
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
por: Toussirot, Eric
Publicado: (2022) -
Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials
por: Toussirot, Eric, et al.
Publicado: (2016) -
The Role of Imaging in Diagnosing Axial Spondyloarthritis
por: Khmelinskii, Nikita, et al.
Publicado: (2018) -
Editorial: Radiographic progression in axial spondyloarthritis
por: Pimentel-Santos, F. M., et al.
Publicado: (2023) -
Axial Spondyloarthritis: Mimics and Pitfalls of Imaging Assessment
por: Caetano, António Proença, et al.
Publicado: (2021)